Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified-release morphine for chronic refractory breathlessness in stable chronic heart failure
2014-000155-81Phase 3Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) comparing Modified-release morphine with Placebo (2 arms). Primary endpoint: Average breathlessness intensity over previous 24 hours at 28 days. Started Sep 2014; status: terminated.
02
Drugs
morphine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2014-000155-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000155-81.